12. Before we decide if we should conduct a detailed investigation of a complaint, we look at whether there are signs the organisation has got something wrong. We do this by comparing what should have happened with what did happen. We have done this and have not found any indications that something has gone wrong.
DNACPR
13. The joint guidance on ‘Decisions relating to cardiopulmonary resuscitation’ describes the process for making a DNACPR decision. It says even when CPR has no realistic prospect of success, there must be a presumption in favour of explaining the need and basis for a DNACPR decision to a patient. There should be clear communication and a record of this.
14. The Trust’s DNACPR form refers to Mrs C’s severe COPD and her COVID-19 infection as reasons why CPR would not be appropriate. The records indicate there was a discussion with Mrs C. There is no evidence of a dispute about whether she should be a candidate for CPR. We understand Miss G does not believe her mother agreed with the DNACPR decision.
15. We appreciate Miss G may have had more confidence if the Trust had also discussed the decision with her. Our adviser explained it would have been better practice to have a discussion with Mrs C’s relatives but the guidance does not say this is necessary. As the Trust appears to have acted in line with the relevant guidance, there is no indication of a failing.
Medication
16. The Trust’s complaint response said it gave Mrs C morphine 2.5mg and midazolam 2.5mg at 5.45pm on 27 September for breathing and agitation. We can see an entry from 8.10pm in Mrs C’s records referring to anticipatory medication and Mrs C’s GCS score being 3.
17. The Glasgow Coma Scale is used to measure a person's level of consciousness. A lower GCS score indicates a more severely impaired consciousness, such as a coma. Our adviser explained Mrs C’s score of 3 indicates she was comatose. There is no evidence of her being given morphine and midazolam prior to this.
18. We do not dispute Miss G’s recollection. We note the Trust has been unable to provide a prescription sheet to confirm what it gave Mrs C and when. We considered whether administering morphine and midazolam would have been in line with the relevant guidance.
19. NICE guidance NG31 explains there are some symptoms and changes that happen to people which can be signs that they are close to death. Section 1.5 of the guidance covers the use of medicines to manage symptoms which are common at the end of life, such as pain and breathlessness.
20. The guidance says breathlessness can be managed with an opioid, or a benzodiazepine, or a combination of an opioid and benzodiazepine. These medications work in different ways. Our adviser said it appears the Trust recognised Mrs C was dying. In line with the guidance, it suggested the use of an opioid (morphine) and/or benzodiazepine (midazolam) if needed.
21. Overall, based on the available information, there is no indication of a failing in the care Mrs C received. We know Miss G has questions about what caused her mother’s deterioration. Sadly, Mrs C appears to have had pneumonia and our adviser said it is likely her deterioration was due to the effects of COVID-19.
22. It is clear Miss G has been deeply affected by her bereavement. We would like to offer our condolences for her loss. We hope our investigation reassures her about the care her mother received and it is clear why we have decided not to consider the complaint further.